Isolation of CD4+CD25+ regulatory T cells for clinical trials

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Petra HoffmannMatthias Edinger

Abstract

The adoptive transfer of donor CD4+CD25+ regulatory T cells has been shown to protect from lethal graft-versus-host disease after allogeneic bone marrow transplantation in murine disease models. Efficient isolation strategies that comply with good manufacturing practice (GMP) guidelines are prerequisites for the clinical application of human CD4+CD25+ regulatory T cells. Here we describe the isolation of CD4+CD25+ T cells with regulatory function from standard leukapheresis products by using a 2-step magnetic cell-separation protocol performed under GMP conditions. The generated cell products contained on average 49.5% CD4+CD25high T cells that phenotypically and functionally represented natural CD4+CD25+ regulatory T cells and showed a suppressive activity comparable to that of CD4+CD25+ regulatory T-cell preparations purified by non-GMP-approved fluorescence-activated cell sorting.

References

Aug 7, 2002·The Journal of Experimental Medicine·Francesco AnnunziatoSergio Romagnani
Aug 7, 2002·The Journal of Experimental Medicine·José L CohenBenoît L Salomon
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Apr 30, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephen C JonesRobert Korngold
Nov 5, 2003·The Journal of Clinical Investigation·Mindi R WalkerSteven F Ziegler
Mar 24, 2004·Seminars in Immunology·Clare Baecher-AllanDavid A Hafler
Jul 8, 2005·Journal of Immunotherapy·Daniel J PowellSteven A Rosenberg

❮ Previous
Next ❯

Citations

Apr 6, 2012·Archivum Immunologiae Et Therapiae Experimentalis·Immo Prinz, Christian Koenecke
Jun 28, 2008·Cancer Immunology, Immunotherapy : CII·Christina Stoeckle, Anne-Kathrin Gleske
Mar 16, 2012·Immunologic Research·Doreen HaaseOlaf Rotzschke
Jul 3, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Piotr TrzonkowskiAndrzej Hellmann
Dec 1, 2009·Bone Marrow Transplantation·S PaczesnyP Reddy
Nov 10, 2010·Immunology and Cell Biology·Clare Y SlaneyJacquie L Harper
Mar 13, 2009·Human Reproduction Update·Leigh R GuerinSarah A Robertson
Sep 28, 2007·Current Opinion in Hematology·Ernst Holler
Oct 9, 2009·Current Opinion in Hematology·Sophie PaczesnyJames L M Ferrara
Nov 10, 2009·Transplantation·Elaine Long, Kathryn J Wood
Oct 18, 2008·The Journal of Clinical Investigation·Milica Vukmanovic-StejicArne N Akbar
Jul 20, 2010·Immunotherapy·Jorieke H PetersIrma Joosten
May 14, 2011·Haematologica·Eleonora TresoldiManuela Battaglia
Nov 5, 2014·Immunopharmacology and Immunotoxicology·Anders Elm PedersenMonika Gad
Nov 21, 2015·Expert Review of Clinical Immunology·Barbarella LucarelliFranco Locatelli
Jul 11, 2013·Current Opinion in Organ Transplantation·Edward K Geissler, James A Hutchinson
Sep 3, 2013·Cytotherapy·J Joseph Melenhorst
Oct 16, 2015·Nephrology·Yuan Min WangStephen I Alexander
Aug 9, 2011·Seminars in Immunology·Keli L HippenBruce R Blazar
Aug 2, 2011·Current Opinion in Immunology·Matthias Edinger, Petra Hoffmann
Mar 15, 2011·Pathology, Research and Practice·Nicola DanieleFrancesco Zinno
Jul 6, 2010·Journal of Immunological Methods·Brigitte BonninChristian Becker
Jul 1, 2009·Trends in Biotechnology·José Luis Corchero, Antonio Villaverde
Jun 30, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Piotr TrzonkowskiAndrzej Hellmann
Nov 6, 2008·Cytotherapy·M Edinger
Jul 11, 2008·The Journal of Gene Medicine·Maude Guillot-DelostFrançois M Lemoine
Mar 19, 2009·Clinical and Experimental Immunology·M Di IanniA Tabilio
Jul 11, 2008·Immunological Reviews·Sarah E AllanMegan K Levings
Jul 11, 2008·Immunological Reviews·Todd M BruskoJeffrey A Bluestone
Jun 12, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N M LerretX Luo
Feb 13, 2014·Immunological Reviews·Ivana R FerrerKathryn J Wood
Jul 6, 2014·European Journal of Immunology·Fatih NoyanElmar Jaeckel
Aug 2, 2006·Current Opinion in Immunology·José L Cohen, Olivier Boyer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.